{{Underlinked|date=February 2016}}
{{Drugbox
| verifiedrevid = 448184192
| IUPAC_name = 1,2-Dihydro-4''H''-pyrazolo[3,4-''d'']pyrimidine-4-thione
| image = Tisopurine.png

<!--Clinical data-->
| tradename =  
| Drugs.com = {{drugs.com|international|tisopurine}}
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status =  
| routes_of_administration =

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 5334-23-6
| ATC_prefix = M04
| ATC_suffix = AA02
| PubChem = 667510
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 79F9I2R16M
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D07278
|  ChemSpiderID = 580886

<!--Chemical data-->
| C=5 | H=4 | N=4 | S=1 
| molecular_weight = 152.18 g/mol
|  smiles = c1c2c([nH]n1)ncnc2S
|  StdInChI = 1S/C5H4N4S/c10-5-3-1-8-9-4(3)6-2-7-5/h1-2H,(H2,6,7,8,9,10)
|  StdInChIKey = PYAOPMWCFSVFOT-UHFFFAOYSA-N
}}

'''Tisopurine''' (or '''thiopurinol''') is a drug used in the treatment of [[gout]] in some countries.<ref name=BJClinPharm1974>{{cite journal|last1=DEAN|first1=B.M.|last2=PERRETT|first2=D.|last3=SIMMONDS|first3=H.A.|last4=GRAHAME|first4=R|title=THIOPURINOL: COMPARATIVE ENZYME INHIBITION AND PROTEIN BINDING STUDIES WITH ALLOPURINOL, OXIPURINOL AND 6-MERCAPTOPURINE|journal=British Journal of Clinical Pharmacology|date=April 1974|volume=1|issue=2|pages=119â€“127|doi=10.1111/j.1365-2125.1974.tb00220.x|url=http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2125.1974.tb00220.x/epdf|accessdate=31 August 2015}}</ref> It reduces uric acid production through inhibiting an early stage in its production.<ref name=AnnRhudis1987>{{cite journal|last1=Jawad|first1=A.S.M|title=Alternatives to allopurinol|journal=Annals of the Rheumatic Diseases|date=1987|volume=46|page=493|doi=10.1136/ard.46.6.493-a|url=http://ard.bmj.com/content/46/6/493.1.full.pdf|accessdate=31 August 2015}}</ref>

==References==
{{Reflist|2}}

{{Antigout preparations}}
{{Purinergics}}

[[Category:Thiocarbonyl compounds]]
[[Category:Pyrazolopyrimidines]]
[[Category:Xanthine oxidase inhibitors]]


{{musculoskeletal-drug-stub}}